These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 30167339)

  • 21. Prevalence and factors associated with renal dysfunction in patients on tenofovir disoproxil fumarate-based antiretroviral regimens for HIV infection in Southern India.
    Kumarasamy N; Sundaram S; Poongulali S; Ezhilarasi C; Pradeep A; Chitra D
    J Virus Erad; 2018 Jan; 4(1):37-40. PubMed ID: 29568552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nephrotoxicity Associated with Concomitant Use of Ledipasvir-Sofosbuvir and Tenofovir in a Patient with Hepatitis C Virus and Human Immunodeficiency Virus Coinfection.
    Bunnell KL; Vibhakar S; Glowacki RC; Gallagher MA; Osei AM; Huhn G
    Pharmacotherapy; 2016 Sep; 36(9):e148-53. PubMed ID: 27459733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and significance of proximal renal tubular abnormalities in HIV-infected patients receiving tenofovir.
    Casado JL; Bañón S; Santiuste C; Serna J; Guzman P; Tenorio M; Liaño F; del Rey JM
    AIDS; 2016 Jan; 30(2):231-9. PubMed ID: 26684820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolution of glomerular filtration rate in HIV-infected, HIV-HBV-coinfected and HBV-infected patients receiving tenofovir disoproxil fumarate.
    Pradat P; Le Pogam MA; Okon JB; Trolliet P; Miailhes P; Brochier C; Maynard M; Bailly F; Zoulim F; Cotte L
    J Viral Hepat; 2013 Sep; 20(9):650-7. PubMed ID: 23910650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using the chronic kidney disease guidelines to evaluate the renal safety of tenofovir disoproxil fumarate in hepatitis B patients.
    Tsai HJ; Chuang YW; Lee SW; Wu CY; Yeh HZ; Lee TY
    Aliment Pharmacol Ther; 2018 Jun; 47(12):1673-1681. PubMed ID: 29696665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early switching of tenofovir disoproxil fumarate (TDF) in HIV-infected patients with TDF-induced nephrotoxicity: a prospective study.
    Patamatamkul S; Songumpai N; Payoong P; Katavetin P; Putcharoen O
    HIV Res Clin Pract; 2022 Aug; 23(1):99-106. PubMed ID: 36065999
    [No Abstract]   [Full Text] [Related]  

  • 27. The significance of antiretroviral-associated acute kidney injury in a cohort of ambulatory human immunodeficiency virus-infected patients.
    Wikman P; Safont P; Del Palacio M; Moreno A; Moreno S; Casado JL
    Nephrol Dial Transplant; 2013 Aug; 28(8):2073-81. PubMed ID: 23739150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of renal Fanconi syndrome in patients taking antiretroviral therapy including tenofovir disoproxil fumarate.
    Medland NA; Chow EP; Walker RG; Chen M; Read TR; Fairley CK
    Int J STD AIDS; 2018 Mar; 29(3):227-236. PubMed ID: 28764611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of renal events during tenofovir disoproxil fumarate and entecavir antiviral prophylaxis in HBsAg-positive cancer patients undergoing chemotherapy.
    Lee IC; Chao Y; Li CP; Su CW; Lan KH; Lin HC; Hou MC; Huang YH
    J Viral Hepat; 2018 Dec; 25(12):1599-1607. PubMed ID: 30125436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal Toxicity of Concomitant Exposure to Tenofovir and Inhibitors of Tenofovir's Renal Efflux Transporters in Patients Infected With HIV Type 1.
    Rokx C; Alshangi H; Verbon A; Zietse R; Hoorn EJ; Rijnders BJ
    J Infect Dis; 2016 Feb; 213(4):561-8. PubMed ID: 26401025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in Kidney Function and in the Rate of Tubular Dysfunction After Tenofovir Withdrawal or Continuation in HIV-Infected Patients.
    Casado JL; Del Rey JM; Bañón S; Santiuste C; Rodriguez M; Moreno A; Perez-Elías MJ; Liaño F; Moreno S
    J Acquir Immune Defic Syndr; 2016 Aug; 72(4):416-22. PubMed ID: 26962850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tenofovir Disoproxil Fumarate-Associated Renal Dysfunction Among Adult People Living with HIV at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia, 2019: A Comparative Retrospective Cohort Study.
    Debeb SG; Muche AA; Kifle ZD; Sema FD
    HIV AIDS (Auckl); 2021; 13():491-503. PubMed ID: 34007217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of chronic kidney disease among HIV-1-infected patients receiving a combination antiretroviral therapy.
    Calza L; Sachs M; Colangeli V; Borderi M; Granozzi B; Malosso P; Comai G; Corradetti V; La Manna G; Viale P
    Clin Exp Nephrol; 2019 Nov; 23(11):1272-1279. PubMed ID: 31327092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Switching to abacavir versus use of a nucleoside-sparing dual regimen for HIV-infected patients with tenofovir-associated renal toxicity.
    Casado JL; Santiuste C; Vivancos MJ; Monsalvo M; Moreno A; Perez-Elías MJ; Del Rey JM; Moreno S
    HIV Med; 2018 Jun; ():. PubMed ID: 29932293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recovery of renal function after early versus late switching of tenofovir disoproxil fumarate in people living with HIV with renal insufficiency.
    Suppadungsuk S; Janepiriyaprayoon P; Sungkanuparph S
    Int J STD AIDS; 2022 Mar; 33(4):391-396. PubMed ID: 35143730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Single-Nucleotide Polymorphism in ABCC4 Is Associated with Tenofovir-Related Beta2-Microglobulinuria in Thai Patients with HIV-1 Infection.
    Likanonsakul S; Suntisuklappon B; Nitiyanontakij R; Prasithsirikul W; Nakayama EE; Shioda T; Sangsajja C
    PLoS One; 2016; 11(1):e0147724. PubMed ID: 26807589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subclinical tubular injury in HIV-infected individuals on antiretroviral therapy: a cross-sectional analysis.
    Hall AM; Edwards SG; Lapsley M; Connolly JO; Chetty K; O'Farrell S; Unwin RJ; Williams IG
    Am J Kidney Dis; 2009 Dec; 54(6):1034-42. PubMed ID: 19783343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of renal dysfunction among HIV infected patients receiving Tenofovir at Mulago: a cross-sectional study.
    Nyende L; Kalyesubula R; Sekasanvu E; Byakika-Kibwika P
    BMC Nephrol; 2020 Jun; 21(1):232. PubMed ID: 32571236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute Kidney Injury, Risk Factors, and Prognosis in Hospitalized HIV-Infected Adults in South Africa, Compared by Tenofovir Exposure.
    Seedat F; Martinson N; Motlhaoleng K; Abraham P; Mancama D; Naicker S; Variava E
    AIDS Res Hum Retroviruses; 2017 Jan; 33(1):33-40. PubMed ID: 27478997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of Decline of Kidney Function in Human Immunodeficiency Virus-Infected Patients Under Routine Clinical Management.
    Boucquemont J; Lawson-Ayayi S; Rigothier C; Bonnet F; Proust-Lima C; Neau D; Greib C; Miremont-Salamé G; Dabis F; Dupon M; Dauchy FA;
    Nephron; 2017; 136(3):211-220. PubMed ID: 28445881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.